Provided herein are compositions, methods, and kits suitable for detection and / or quantification of
calprotectin in a sample (including extracts thereof). In some aspects, compositions, methods, and / or kits comprise a Fab-Enabled Split
Luciferase Calprotectin Assay (FESCA) or components thereof, a novel quantitative method for
calprotectin measurement. In some aspects, provided herein are two new fragment
antigen binding proteins (Fabs), CP16 and CP17, which bind to different epitopes of the
calprotectin complex. These Fabs can be fused, directly or indirectly, with a reporter
system, such as split NanoLuciferase fragments, enabling the reconstitution of active
luciferase upon binding to calprotectin either in solution or in varied immobilized
assay formats. Technologies provided herein can be utilized to detect physiologically relevant calprotectin levels across various sample types, including serum,
plasma,
whole blood, and stool extracts, and can be utilized in methods of treating a subject.